Hierarchical cysteine oxidation controls reversible amyloid formation in an ankyrin repeat protein

Proteins are the workhorses of life, tiny machines that fold into precise three-dimensional shapes to perform specific tasks. Usually, a protein's shape is its identity; if it loses that shape, it stops working. For decades, scientists believed that when proteins lost their shape and clumped together into rigid, rope-like fibers called amyloids, it was a sign of disease or death. These amyloid clumps are the hallmark of conditions like Alzheimer's and Parkinson's, where they clog the brain and destroy cells. However, a growing body of research has revealed that some proteins can deliberately switch into these amyloid shapes to perform useful jobs, such as storing hormones or building protective barriers. The big mystery has been how a cell controls this switch. How does a protein know when to stay as a flexible, working tool and when to lock itself into a rigid, fibrous structure without causing harm?

A team of researchers in New Zealand has uncovered a sophisticated chemical switch in a protein from zebrafish that answers this question. They studied a protein called drP18, which acts as a brake on cell division, helping to prevent tumors. This protein contains two special spots, known as cysteine residues, which act like chemical handles. The researchers discovered that these two handles do not work independently. Instead, they operate in a strict hierarchy, where one handle controls the other. When the protein is exposed to specific chemical signals found in the body, the first handle locks the second one away, keeping the protein safe and functional. But if the chemical conditions change, the first handle gets blocked by a different molecule, freeing the second handle to grab onto other proteins. This triggers a rapid transformation where the proteins link together into long, reversible amyloid fibers. Remarkably, the researchers found that this entire process is controlled by the type of chemical oxidant present, and the resulting fibers can be taken apart just as easily as they were built, restoring the protein to its original, working state.

The story begins with the discovery that this zebrafish protein, drP18, behaves differently than its human cousin. While the human version has only one of these chemical handles, the zebrafish version has two, positioned far apart on the protein's surface. The researchers wanted to see if these two handles created a more complex control system. They started by exposing the protein to various common oxidizing agents, which are chemicals that remove electrons and can change how proteins behave. When they used a chemical called diamide, the two handles on a single protein molecule grabbed each other, forming a loop inside the protein. This internal loop acted as a safety lock, preventing the protein from clumping together. The protein remained flexible and single, unable to form the rigid fibers associated with amyloids.

However, the outcome changed completely when the researchers introduced a different chemical called hypothiocyanous acid, which is produced by the immune system. Under these conditions, the first handle, located at position 50, did not grab the second handle. Instead, it became coated with a small molecule called glutathione, which is abundant in cells. This coating acted as a shield, blocking the first handle from locking onto the second. With the first handle occupied, the second handle, located at position 128, was left free. When the oxidizing chemical arrived, this free handle reached out and grabbed the same handle on a neighboring protein. This created a chain reaction, linking many proteins together into dimers and then into long, rope-like fibers. The researchers confirmed these fibers were amyloids by observing how they scattered light and by looking at them under powerful microscopes, where they appeared as distinct, thread-like structures.

What made this discovery truly unique was the realization that the protein could switch back and forth. The researchers added a reducing agent, a chemical that breaks the bonds holding the proteins together, and watched the long fibers dissolve back into individual, working proteins. This reversibility proved that the amyloid formation was not a sign of damage or disease, but a controlled, functional process. The team then tested whether the type of oxidizing chemical mattered. They found that different chemicals produced amyloid fibers with different shapes and speeds of formation. Some chemicals created long, bundled ropes, while others made shorter, more fragmented threads. This suggested that the cell could potentially tune the structure of the amyloid fibers simply by changing the chemical environment, allowing for different functional outcomes.

To understand how this mechanism worked at the molecular level, the researchers looked closely at the two handles. They measured the chemical potential of each handle to determine which one reacted first. They found that the handle at position 50 was more reactive and would oxidize before the one at position 128. This confirmed the hierarchical nature of the switch: the first handle acts as a regulator, deciding whether the second handle is available to do its job. When the first handle is free, it locks the second one down, keeping the protein in its safe, single form. When the first handle is blocked by glutathione, the second handle is released to build the amyloid structure. This two-step process ensures that the protein only forms amyloids when the specific chemical conditions are right.

The researchers also tested what happened to the protein's function during this transformation. In its normal, single form, the protein acts as a brake on a key enzyme called CDK4, which drives cell division. They found that when the protein formed amyloid fibers, it lost this ability to stop the enzyme. The cell division brake was effectively turned off. However, when they broke the fibers apart and returned the protein to its single form, it regained its ability to stop the enzyme. This showed that the switch between the single form and the amyloid form was a direct way to turn the protein's function on and off. The amyloid state was not a dead end; it was a temporary, reversible storage or inactivation state.

To see if this happened in a living organism, the researchers injected the genetic instructions for the protein into zebrafish embryos. As the embryos grew, the protein formed clumps that stained with a dye known to bind to amyloid structures. These clumps were visible inside the cells and disappeared when the researchers treated the tissue with a reducing agent. This confirmed that the protein could undergo this oxidation-driven transformation inside a living animal, likely triggered by the natural oxidizing chemicals present during development. The findings suggest that nature has evolved a way to use the same chemical principles that cause disease in humans to create a functional, reversible switch in other organisms.

This work challenges the old view that amyloid formation is always a sign of cellular failure. Instead, it shows that proteins can encode complex, multi-step instructions to control their own assembly. The zebrafish protein uses a regulatory handle to guard an executioner handle, creating a sophisticated chemical switch that responds to the environment. The ability to build and dismantle these structures on demand suggests that cells might use similar mechanisms to manage other proteins, turning them into temporary storage units or structural scaffolds when needed. The research highlights that the boundary between a functional protein and a pathological clump is not fixed, but can be crossed and recrossed through precise chemical control. By understanding how these switches work, scientists may gain new insights into how cells regulate their most critical processes and how to potentially manipulate these pathways in the future.